ACETAMINOPHEN AND DIPHENHYDRAMINE HCL

ACETAMINOPHEN AND DIPHENHYDRAMINE HCL was reported 3367 times

ACETAMINOPHEN AND DIPHENHYDRAMINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOLLICULAR LYMPHOMA REFRACTORY 5 0.0769
1 URETERIC HAEMORRHAGE 5 0.0725
2 TESTICULAR OPERATION 4 0.0714
3 GRIP STRENGTH 13 0.0568
4 DENGUE HAEMORRHAGIC FEVER 3 0.0469
5 NASAL HERPES 8 0.0394
6 HEPATIC ENZYME 5 0.0336
7 HYPOAESTHESIA EYE 19 0.0322
8 ACTION TREMOR 5 0.0309
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 20 0.0299
10 FOETAL CHROMOSOME ABNORMALITY 5 0.0294
11 STEROID DEPENDENCE 23 0.0262
12 REDUCED FACIAL EXPRESSION 26 0.0256
13 DEEP VEIN THROMBOSIS POSTOPERATIVE 49 0.0245
14 CATARRH 22 0.0243
15 LUPUS VULGARIS 29 0.0230
16 C-REACTIVE PROTEIN 21 0.0227
17 FACET JOINT SYNDROME 70 0.0215
18 RHEUMATIC FEVER 90 0.0202
19 SWOLLEN JOINT COUNT INCREASED 64 0.0201
20 SWOLLEN JOINT COUNT 5 0.0200
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 11 0.0196
22 MERALGIA PARAESTHETICA 4 0.0190
23 TRANSFERRIN SATURATION DECREASED 8 0.0187
24 X-RAY ABNORMAL 33 0.0184
25 NEUROLOGIC NEGLECT SYNDROME 10 0.0180
26 DUODENAL ULCER PERFORATION 120 0.0161
27 NIPPLE SWELLING 4 0.0159
28 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 33 0.0159
29 PERIPHERAL VENOUS DISEASE 60 0.0147
30 RETINITIS 25 0.0145
31 DISLOCATION OF VERTEBRA 33 0.0145
32 MEAN PLATELET VOLUME DECREASED 12 0.0143
33 HYPOCHOLESTEROLAEMIA 5 0.0142
34 GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0140
35 ABDOMINAL LYMPHADENOPATHY 12 0.0138
36 AUTOIMMUNE NEPHRITIS 3 0.0136
37 NEUTROPENIC INFECTION 13 0.0136
38 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 95 0.0132
39 ANTIPSYCHOTIC DRUG LEVEL DECREASED 7 0.0132
40 RHEUMATOID FACTOR POSITIVE 74 0.0128
41 BLISTER INFECTED 10 0.0128
42 PORPHYRIA ACUTE 18 0.0125
43 BURNS SECOND DEGREE 22 0.0125
44 MUSCLE INJURY 103 0.0124
45 MONOCYTE COUNT DECREASED 15 0.0123
46 C-REACTIVE PROTEIN DECREASED 8 0.0123
47 HELICOBACTER INFECTION 124 0.0121
48 FOLLICULITIS 126 0.0120
49 CAROTID ARTERY THROMBOSIS 10 0.0118
50 C-REACTIVE PROTEIN ABNORMAL 74 0.0115
51 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 74 0.0114
52 IMMUNODEFICIENCY COMMON VARIABLE 5 0.0102
53 LISTLESS 33 0.0100
54 PEMPHIGUS 125 0.0100
55 HAND DEFORMITY 128 0.0097
56 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
57 ALCOHOL POISONING 23 0.0086
58 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 14 0.0084
59 PERICARDITIS 139 0.0083
60 LIP DRY 74 0.0081
61 ONYCHOMADESIS 34 0.0081
62 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
63 ONYCHOMYCOSIS 35 0.0080
64 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 5 0.0078
65 ADJUSTMENT DISORDER 10 0.0077
66 VESTIBULAR NEURONITIS 4 0.0075
67 HYPERCHOLESTEROLAEMIA 72 0.0074
68 BREAST CANCER STAGE III 48 0.0074
69 SYNOVITIS 130 0.0072
70 JOINT RANGE OF MOTION DECREASED 88 0.0066
71 HYPOPNOEA 22 0.0063
72 GRIP STRENGTH DECREASED 55 0.0062
73 BONE EROSION 22 0.0062
74 ARTERIOVENOUS FISTULA 3 0.0061
75 BURSITIS 72 0.0059
76 STREPTOCOCCAL SEPSIS 7 0.0059
77 GLOSSODYNIA 128 0.0057
78 FACIAL DISCOMFORT 4 0.0056
79 IRRITABLE BOWEL SYNDROME 119 0.0055
80 WOUND INFECTION 60 0.0055
81 CHIKUNGUNYA VIRUS INFECTION 3 0.0054
82 LIVE BIRTH 44 0.0053
83 AUTOIMMUNE DISORDER 49 0.0050
84 WOUND 137 0.0049
85 IMMOBILE 21 0.0048
86 MATERNAL EXPOSURE TIMING UNSPECIFIED 18 0.0048
87 SYSTEMIC LUPUS ERYTHEMATOSUS 170 0.0048
88 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
89 MEDICATION OVERUSE HEADACHE 4 0.0047
90 GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0045
91 FOREIGN BODY 18 0.0045
92 FACIAL SPASM 5 0.0045
93 VULVOVAGINAL CANDIDIASIS 6 0.0044
94 RED CELL DISTRIBUTION WIDTH INCREASED 18 0.0043
95 FIBROMYALGIA 104 0.0043
96 IMPAIRED HEALING 136 0.0041
97 BLEPHAROSPASM 26 0.0041
98 PRODUCT LABEL CONFUSION 24 0.0041
99 OBESITY 65 0.0041
100 BRAIN STEM SYNDROME 3 0.0040
101 LIVER INJURY 98 0.0040
102 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
103 PERIARTHRITIS 9 0.0040
104 TROPONIN T INCREASED 5 0.0039
105 PARAINFLUENZAE VIRUS INFECTION 6 0.0039
106 EYE COLOUR CHANGE 4 0.0039
107 SCIATICA 61 0.0038
108 PERSONALITY DISORDER 10 0.0038
109 SYSTOLIC DYSFUNCTION 4 0.0038
110 TUMOUR PAIN 5 0.0038
111 FINGER DEFORMITY 18 0.0037
112 URETERIC OBSTRUCTION 5 0.0037
113 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
114 METABOLIC SYNDROME 6 0.0036
115 AFFECT LABILITY 35 0.0036
116 PELVIC FRACTURE 28 0.0036
117 NAIL DISORDER 31 0.0035
118 RED BLOOD CELL SEDIMENTATION RATE INCREASED 39 0.0035
119 TYPE 2 DIABETES MELLITUS 118 0.0035
120 SERONEGATIVE ARTHRITIS 4 0.0035
121 BRONCHIECTASIS 23 0.0034
122 LOWER RESPIRATORY TRACT INFECTION 149 0.0033
123 LIVER FUNCTION TEST INCREASED 69 0.0032
124 PAROSMIA 24 0.0032
125 TESTICULAR SWELLING 4 0.0032
126 RHINITIS 25 0.0031
127 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
128 STOMA SITE INFECTION 4 0.0031
129 LOWER LIMB FRACTURE 58 0.0030
130 GINGIVAL PAIN 24 0.0030
131 EYE INJURY 9 0.0030
132 PSORIATIC ARTHROPATHY 120 0.0030
133 PUSTULAR PSORIASIS 10 0.0029
134 RASH VESICULAR 14 0.0029
135 CARDIAC MURMUR 25 0.0029
136 HYPOPITUITARISM 5 0.0029
137 COELIAC DISEASE 28 0.0029
138 EXOSTOSIS 26 0.0028
139 HYPERKINESIA 6 0.0028
140 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 17 0.0027
141 DELIRIUM 94 0.0027
142 PRESCRIBED OVERDOSE 51 0.0026
143 GAIT INABILITY 88 0.0026
144 PULMONARY FIBROSIS 50 0.0026
145 APATHY 38 0.0026
146 C-REACTIVE PROTEIN INCREASED 94 0.0026
147 WALKING AID USER 17 0.0026
148 NORMAL NEWBORN 14 0.0026
149 DRUG TOLERANCE DECREASED 7 0.0025
150 INFUSION RELATED REACTION 162 0.0024
151 VASOPLEGIA SYNDROME 4 0.0024
152 HYPERPARATHYROIDISM 5 0.0024
153 BAND SENSATION 3 0.0024
154 JOINT DISLOCATION 25 0.0024
155 BLOOD CHOLESTEROL INCREASED 110 0.0024
156 MYOSITIS 21 0.0023
157 SERUM FERRITIN DECREASED 4 0.0023
158 BACK INJURY 25 0.0023
159 CONTRAINDICATED PRODUCT ADMINISTERED 68 0.0022
160 ULCER HAEMORRHAGE 15 0.0022
161 OROPHARYNGEAL DISCOMFORT 20 0.0022
162 NIGHT SWEATS 71 0.0022
163 SPONDYLITIS 8 0.0022
164 CUSHINGOID 7 0.0022
165 CALCIPHYLAXIS 4 0.0022
166 OSTEOARTHRITIS 92 0.0022
167 HEMIPLEGIA 18 0.0022
168 ARTHROPATHY 120 0.0022
169 HEPATIC ENZYME INCREASED 146 0.0021
170 STOMA SITE ERYTHEMA 4 0.0021
171 CHRONIC SINUSITIS 8 0.0021
172 ALVEOLITIS 3 0.0021
173 BLISTER 119 0.0021
174 MOBILITY DECREASED 150 0.0021
175 FOOT DEFORMITY 23 0.0021
176 SCHIZOPHRENIA 25 0.0021
177 BREAST CANCER STAGE II 17 0.0020
178 DISCOMFORT 124 0.0020
179 GANGRENE 12 0.0020
180 HEAD DISCOMFORT 35 0.0020
181 IMMUNE-MEDIATED HEPATITIS 4 0.0020
182 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
183 LUPUS-LIKE SYNDROME 17 0.0019
184 ILL-DEFINED DISORDER 113 0.0019
185 ABSCESS INTESTINAL 4 0.0019
186 NIGHTMARE 64 0.0018
187 STOMA SITE DISCHARGE 5 0.0018
188 IMMUNODEFICIENCY 27 0.0018
189 FAECES PALE 4 0.0018
190 INJURY 126 0.0018
191 STOMATITIS 107 0.0018
192 LIVER DISORDER 78 0.0018
193 GENERAL PHYSICAL HEALTH DETERIORATION 201 0.0017
194 WHEEZING 102 0.0017
195 EMOTIONAL POVERTY 3 0.0017
196 BLOOD IRON DECREASED 20 0.0017
197 SWELLING 157 0.0017
198 INFLAMMATION 86 0.0017
199 CEREBROVASCULAR DISORDER 5 0.0017
200 BONE MARROW DISORDER 5 0.0017
201 HEPATIC CIRRHOSIS 31 0.0016
202 UTERINE LEIOMYOMA 12 0.0016
203 SLEEP DISORDER 115 0.0016
204 RETROPERITONEAL HAEMORRHAGE 4 0.0016
205 SENSORY LOSS 13 0.0016
206 INFLAMMATORY MARKER INCREASED 8 0.0016
207 IMPAIRED QUALITY OF LIFE 23 0.0016
208 PREGNANCY 32 0.0016
209 SQUAMOUS CELL CARCINOMA 15 0.0016
210 FREQUENT BOWEL MOVEMENTS 43 0.0016
211 CONFUSIONAL STATE 255 0.0016
212 MOTOR DYSFUNCTION 16 0.0016
213 MUSCULOSKELETAL PAIN 81 0.0015
214 SPINAL CORD COMPRESSION 6 0.0015
215 ABDOMINAL WALL HAEMATOMA 3 0.0015
216 LUNG DISORDER 75 0.0015
217 URINARY RETENTION 51 0.0015
218 TASTE DISORDER 31 0.0015
219 VITAMIN D DECREASED 13 0.0015
220 CEREBRAL ATROPHY 6 0.0015
221 POOR QUALITY SLEEP 32 0.0015
222 MUSCULOSKELETAL STIFFNESS 130 0.0015
223 OEDEMA 80 0.0015
224 NEUTROPHIL COUNT INCREASED 15 0.0015
225 PRESCRIBED UNDERDOSE 29 0.0015
226 LEFT VENTRICULAR FAILURE 5 0.0015
227 BEDRIDDEN 19 0.0014
228 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
229 ROAD TRAFFIC ACCIDENT 60 0.0014
230 CONTUSION 138 0.0014
231 GASTROINTESTINAL DISORDER 128 0.0014
232 PROCTITIS 4 0.0014
233 DILATATION VENTRICULAR 3 0.0014
234 RHEUMATOID ARTHRITIS 161 0.0014
235 SEDATION 37 0.0014
236 UROSEPSIS 13 0.0014
237 CARDIAC FAILURE CHRONIC 6 0.0014
238 ABSCESS LIMB 6 0.0014
239 FIBRIN D DIMER INCREASED 5 0.0014
240 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
241 PYODERMA GANGRENOSUM 5 0.0014
242 MUSCLE SPASTICITY 17 0.0014
243 JOINT SWELLING 165 0.0014
244 THORACIC VERTEBRAL FRACTURE 4 0.0014
245 FREEZING PHENOMENON 5 0.0013
246 PERIORBITAL OEDEMA 7 0.0013
247 GENERAL SYMPTOM 10 0.0013
248 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
249 HEPATIC NECROSIS 5 0.0013
250 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
251 DRY MOUTH 107 0.0013
252 TROPONIN INCREASED 10 0.0013
253 DENGUE FEVER 3 0.0013
254 LOCALISED OEDEMA 6 0.0013
255 MEDICATION ERROR 72 0.0013
256 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
257 RHINOVIRUS INFECTION 5 0.0013
258 ADVERSE REACTION 17 0.0013
259 BLOOD CREATININE DECREASED 4 0.0013
260 ESCHERICHIA BACTERAEMIA 3 0.0013
261 DRUG-INDUCED LIVER INJURY 40 0.0013
262 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
263 LIVER FUNCTION TEST ABNORMAL 37 0.0013
264 TESTICULAR PAIN 4 0.0013
265 NEUTROPENIC SEPSIS 9 0.0013
266 POLYMYALGIA RHEUMATICA 4 0.0013
267 LYMPHOCYTE COUNT DECREASED 22 0.0012
268 HAEMOGLOBIN ABNORMAL 8 0.0012
269 NEUROLOGICAL SYMPTOM 7 0.0012
270 ANAL INCONTINENCE 11 0.0012
271 DERMAL CYST 3 0.0012
272 MYOCARDITIS 14 0.0012
273 SELF-MEDICATION 5 0.0012
274 PNEUMONITIS 33 0.0012
275 HEPATITIS 31 0.0012
276 OTITIS MEDIA 4 0.0012
277 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
278 CONGESTIVE CARDIOMYOPATHY 5 0.0012
279 METASTASES TO SPINE 4 0.0012
280 RECTAL HAEMORRHAGE 51 0.0012
281 BRADYKINESIA 7 0.0012
282 THERAPEUTIC PRODUCT EFFECT DECREASED 53 0.0012
283 VERTIGO 72 0.0012
284 HEPATIC CYST 4 0.0012
285 CANCER PAIN 3 0.0012
286 FACIAL PARALYSIS 10 0.0012
287 FEMORAL NECK FRACTURE 6 0.0012
288 FOOD ALLERGY 9 0.0012
289 INTENTIONAL PRODUCT USE ISSUE 102 0.0012
290 BLOOD CHLORIDE DECREASED 3 0.0012
291 PLATELET COUNT INCREASED 15 0.0011
292 COMPARTMENT SYNDROME 3 0.0011
293 ENCEPHALOPATHY 28 0.0011
294 JAUNDICE CHOLESTATIC 4 0.0011
295 EXPOSURE DURING PREGNANCY 70 0.0011
296 MATERNAL EXPOSURE DURING PREGNANCY 100 0.0011
297 OVERWEIGHT 6 0.0011
298 HIP ARTHROPLASTY 17 0.0011
299 BLADDER DISORDER 11 0.0011
300 SINUSITIS 113 0.0011
301 HYPERTENSION 232 0.0011
302 KNEE ARTHROPLASTY 23 0.0011
303 THROAT TIGHTNESS 29 0.0011
304 PERFORMANCE STATUS DECREASED 5 0.0011
305 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
306 FRACTURE 20 0.0011
307 CLAVICLE FRACTURE 4 0.0010
308 BLOOD URIC ACID INCREASED 6 0.0010
309 MIGRAINE 99 0.0010
310 COMA SCALE ABNORMAL 3 0.0010
311 RALES 6 0.0010
312 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
313 HYPONATRAEMIA 58 0.0010
314 SPLENOMEGALY 12 0.0010
315 EPILEPSY 31 0.0010
316 INJECTION SITE INFLAMMATION 5 0.0010
317 HYPERAMMONAEMIA 5 0.0010
318 BLEPHARITIS 4 0.0010
319 HYPOAESTHESIA 149 0.0010
320 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
321 PALLOR 27 0.0010
322 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
323 HYPERSENSITIVITY 183 0.0010
324 COLITIS ULCERATIVE 44 0.0010
325 BACK DISORDER 16 0.0010
326 RESTLESSNESS 36 0.0010
327 ABDOMINAL DISCOMFORT 165 0.0010
328 EAR INFECTION 26 0.0010
329 IRON DEFICIENCY ANAEMIA 9 0.0010
330 CHOLANGITIS 6 0.0010
331 FOETAL DEATH 5 0.0010
332 HAEMOGLOBIN DECREASED 99 0.0010
333 INFECTION 139 0.0010
334 BLOOD BLISTER 3 0.0010
335 HAEMATOCRIT DECREASED 19 0.0010
336 NECK PAIN 53 0.0009
337 SKIN HAEMORRHAGE 14 0.0009
338 HEMIPARESIS 16 0.0009
339 PYREXIA 324 0.0009
340 HERNIA 18 0.0009
341 SWOLLEN TONGUE 29 0.0009
342 STRESS FRACTURE 5 0.0009
343 OXYGEN SATURATION DECREASED 52 0.0009
344 COGNITIVE DISORDER 43 0.0009
345 BOWEL MOVEMENT IRREGULARITY 7 0.0009
346 RED BLOOD CELL COUNT DECREASED 26 0.0009
347 INTESTINAL ISCHAEMIA 5 0.0009
348 CONGENITAL ANOMALY 7 0.0009
349 PARAESTHESIA ORAL 13 0.0009
350 DRUG INTOLERANCE 87 0.0009
351 CYTOKINE RELEASE SYNDROME 18 0.0009
352 EMPHYSEMA 9 0.0009
353 IRON DEFICIENCY 4 0.0009
354 POSTOPERATIVE WOUND INFECTION 6 0.0009
355 SINUS CONGESTION 12 0.0009
356 RESPIRATORY TRACT CONGESTION 14 0.0009
357 NEUTROPHILIA 5 0.0009
358 LUMBAR VERTEBRAL FRACTURE 4 0.0009
359 ORAL HERPES 17 0.0009
360 BLOOD CREATININE ABNORMAL 3 0.0009
361 HYPOKALAEMIA 40 0.0009
362 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
363 AORTIC STENOSIS 3 0.0009
364 RENAL FUNCTION TEST ABNORMAL 4 0.0009
365 METABOLIC DISORDER 5 0.0009
366 COORDINATION ABNORMAL 12 0.0009
367 FEBRILE NEUTROPENIA 57 0.0009
368 HYPOVOLAEMIA 5 0.0009
369 INCONTINENCE 9 0.0009
370 PERIPHERAL SWELLING 131 0.0008
371 ACCIDENTAL OVERDOSE 31 0.0008
372 IMPAIRED WORK ABILITY 18 0.0008
373 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
374 JOINT STIFFNESS 22 0.0008
375 BREAST CANCER METASTATIC 9 0.0008
376 ANGINA PECTORIS 24 0.0008
377 TUMOUR MARKER INCREASED 4 0.0008
378 AMNESIA 54 0.0008
379 ARTHRITIS 65 0.0008
380 INGUINAL HERNIA 5 0.0008
381 OEDEMA PERIPHERAL 100 0.0008
382 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
383 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
384 DYSPEPSIA 80 0.0008
385 ALCOHOL USE 3 0.0008
386 AMYLASE INCREASED 3 0.0008
387 MYOPATHY 7 0.0008
388 FOOT OPERATION 4 0.0008
389 NASOPHARYNGITIS 148 0.0008
390 HEPATIC ENZYME ABNORMAL 4 0.0008
391 TREATMENT FAILURE 66 0.0008
392 ERYSIPELAS 4 0.0008
393 CORONARY ARTERY STENOSIS 4 0.0008
394 MUSCULAR WEAKNESS 90 0.0008
395 VULVOVAGINAL PRURITUS 4 0.0008
396 COMMUNICATION DISORDER 3 0.0008
397 THERAPY NON-RESPONDER 35 0.0008
398 MUSCULOSKELETAL CHEST PAIN 12 0.0008
399 EAR PAIN 15 0.0008
400 SKIN NECROSIS 4 0.0008
401 HEPATITIS ACUTE 5 0.0008
402 TONSILLITIS 4 0.0008
403 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
404 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
405 LETHARGY 44 0.0008
406 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
407 HYPOGAMMAGLOBULINAEMIA 5 0.0008
408 HYPERTHYROIDISM 11 0.0008
409 ORAL CANDIDIASIS 10 0.0008
410 POLYARTHRITIS 4 0.0008
411 DISABILITY 15 0.0008
412 SERUM FERRITIN INCREASED 4 0.0008
413 URTICARIA 127 0.0008
414 BLOOD ALBUMIN DECREASED 6 0.0008
415 OSTEOPOROSIS 31 0.0008
416 MALIGNANT MELANOMA 10 0.0007
417 POST-TRAUMATIC STRESS DISORDER 5 0.0007
418 DECREASED APPETITE 171 0.0007
419 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
420 METASTASES TO BONE 12 0.0007
421 ARTHRITIS BACTERIAL 3 0.0007
422 EYE MOVEMENT DISORDER 5 0.0007
423 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
424 ECCHYMOSIS 5 0.0007
425 ACUTE CORONARY SYNDROME 6 0.0007
426 PAIN IN EXTREMITY 213 0.0007
427 DIVERTICULITIS 20 0.0007
428 ALOPECIA 140 0.0007
429 URINARY INCONTINENCE 21 0.0007
430 ASTHMA 80 0.0007
431 HAEMATOCHEZIA 39 0.0007
432 WEIGHT INCREASED 156 0.0007
433 APHASIA 21 0.0007
434 HAEMATOMA 18 0.0007
435 MOUTH SWELLING 4 0.0007
436 DYSARTHRIA 26 0.0007
437 ATRIAL FIBRILLATION 67 0.0007
438 BODY TEMPERATURE INCREASED 14 0.0007
439 CHEST PAIN 127 0.0007
440 DYSPHEMIA 3 0.0007
441 SPINAL PAIN 8 0.0007
442 RIB FRACTURE 14 0.0007
443 GASTROOESOPHAGEAL REFLUX DISEASE 54 0.0007
444 RESPIRATORY DISORDER 20 0.0007
445 HYPERHIDROSIS 86 0.0007
446 HAEMORRHOIDS 13 0.0007
447 MOUTH ULCERATION 14 0.0007
448 NEURALGIA 16 0.0007
449 EATING DISORDER 14 0.0007
450 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
451 LIPASE INCREASED 5 0.0007
452 NERVE COMPRESSION 6 0.0006
453 SPINAL FRACTURE 13 0.0006
454 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
455 ARTHRITIS INFECTIVE 3 0.0006
456 PHARYNGITIS 8 0.0006
457 APPENDICITIS 6 0.0006
458 CONDITION AGGRAVATED 193 0.0006
459 TINNITUS 29 0.0006
460 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
461 HEPATIC FAILURE 19 0.0006
462 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
463 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
464 PANCREATITIS 33 0.0006
465 SNEEZING 14 0.0006
466 SENSORY DISTURBANCE 10 0.0006
467 ATELECTASIS 6 0.0006
468 LIMB DISCOMFORT 19 0.0006
469 ASPHYXIA 5 0.0006
470 ASCITES 18 0.0006
471 POLYP 4 0.0006
472 CARDIOMYOPATHY 9 0.0006
473 ESCHERICHIA INFECTION 5 0.0006
474 COLITIS 23 0.0006
475 SINUS DISORDER 12 0.0006
476 ABDOMINAL TENDERNESS 3 0.0006
477 HYPOACUSIS 26 0.0006
478 SKIN MASS 4 0.0006
479 ABDOMINAL PAIN UPPER 123 0.0006
480 MOOD SWINGS 19 0.0006
481 SUICIDE ATTEMPT 36 0.0006
482 METASTASES TO LYMPH NODES 4 0.0006
483 PARAESTHESIA 93 0.0006
484 DYSLIPIDAEMIA 3 0.0006
485 HEPATIC STEATOSIS 11 0.0006
486 NEPHROLITHIASIS 27 0.0006
487 ENDOCARDITIS 3 0.0006
488 PHOTOPHOBIA 11 0.0006
489 HAEMATURIA 20 0.0006
490 MUSCLE SPASMS 107 0.0006
491 TEMPERATURE INTOLERANCE 6 0.0006
492 HYPOCALCAEMIA 11 0.0006
493 BONE PAIN 34 0.0006
494 RESPIRATION ABNORMAL 4 0.0006
495 TOOTH LOSS 12 0.0006
496 VENTRICULAR EXTRASYSTOLES 6 0.0006
497 MENTAL IMPAIRMENT 14 0.0006
498 DIPLOPIA 15 0.0006
499 NERVOUS SYSTEM DISORDER 18 0.0006
500 ACUTE MYOCARDIAL INFARCTION 17 0.0006
501 CHROMATURIA 13 0.0006
502 APLASTIC ANAEMIA 3 0.0006
503 RESPIRATORY DEPRESSION 7 0.0006
504 BLOOD CALCIUM INCREASED 5 0.0006
505 DEEP VEIN THROMBOSIS 37 0.0006
506 SPINAL OSTEOARTHRITIS 5 0.0006
507 PNEUMONIA 184 0.0006
508 FALL 189 0.0006
509 HYPERCALCAEMIA 7 0.0006
510 LYMPHOPENIA 8 0.0006
511 CHOKING 11 0.0006
512 THERMAL BURN 4 0.0006
513 CHILLS 66 0.0006
514 TACHYCARDIA 50 0.0006
515 ANXIETY 160 0.0006
516 FACIAL PAIN 5 0.0006
517 ABDOMINAL PAIN 130 0.0006
518 PULMONARY OEDEMA 25 0.0006
519 PULMONARY EMBOLISM 53 0.0006
520 PALPITATIONS 65 0.0006
521 DEHYDRATION 74 0.0006
522 ECZEMA 29 0.0006
523 ARTHRALGIA 230 0.0006
524 DERMATITIS BULLOUS 4 0.0006
525 MALAISE 242 0.0006
526 RASH 240 0.0006
527 OPTIC NEURITIS 5 0.0005
528 BLOOD GLUCOSE FLUCTUATION 6 0.0005
529 MEMORY IMPAIRMENT 75 0.0005
530 AUTISM SPECTRUM DISORDER 3 0.0005
531 PRODUCT USE IN UNAPPROVED INDICATION 135 0.0005
532 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
533 DYSURIA 20 0.0005
534 OVARIAN CANCER 5 0.0005
535 DEPRESSION 123 0.0005
536 NERVE INJURY 6 0.0005
537 GAIT DISTURBANCE 103 0.0005
538 PAIN 330 0.0005
539 VOMITING 251 0.0005
540 BLOOD CALCIUM DECREASED 6 0.0005
541 INTENTIONAL OVERDOSE 34 0.0005
542 MOVEMENT DISORDER 17 0.0005
543 TENDON PAIN 4 0.0005
544 GASTRIC ULCER 10 0.0005
545 INJECTION SITE REACTION 36 0.0005
546 FEELING HOT 32 0.0005
547 THROMBOCYTOPENIA 58 0.0005
548 INSOMNIA 138 0.0005
549 ABDOMINAL DISTENSION 54 0.0005
550 SINUS BRADYCARDIA 5 0.0005
551 FEMUR FRACTURE 16 0.0005
552 ELECTROLYTE IMBALANCE 6 0.0005
553 CELLULITIS 26 0.0005
554 RETCHING 11 0.0005
555 DYSPNOEA 292 0.0005
556 LUNG INFECTION 8 0.0005
557 BASAL CELL CARCINOMA 8 0.0005
558 PHARYNGEAL SWELLING 5 0.0005
559 GASTROINTESTINAL INFLAMMATION 4 0.0005
560 AFFECTIVE DISORDER 4 0.0005
561 HEPATOMEGALY 5 0.0005
562 CHEST DISCOMFORT 52 0.0005
563 RENAL CYST 4 0.0005
564 TRICUSPID VALVE INCOMPETENCE 4 0.0005
565 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
566 FEELING COLD 14 0.0005
567 CYSTITIS 16 0.0005
568 HEADACHE 315 0.0005
569 HYPERLIPIDAEMIA 6 0.0005
570 GOUT 9 0.0005
571 BLOOD DISORDER 4 0.0005
572 BLOOD TEST ABNORMAL 7 0.0005
573 DEVICE OCCLUSION 7 0.0005
574 TOOTHACHE 9 0.0005
575 MYASTHENIA GRAVIS 4 0.0005
576 VAGINAL DISCHARGE 5 0.0005
577 MUSCLE TIGHTNESS 8 0.0005
578 SUBARACHNOID HAEMORRHAGE 5 0.0005
579 CYTOPENIA 6 0.0005
580 ABNORMAL FAECES 4 0.0005
581 MYELODYSPLASTIC SYNDROME 7 0.0005
582 SPINAL COMPRESSION FRACTURE 4 0.0005
583 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
584 TENDERNESS 5 0.0005
585 INTENTIONAL PRODUCT MISUSE 42 0.0005
586 GASTROENTERITIS 7 0.0005
587 PETECHIAE 5 0.0005
588 FATIGUE 370 0.0005
589 URINARY TRACT INFECTION 81 0.0005
590 INFUSION SITE ERYTHEMA 4 0.0005
591 BLOOD URINE PRESENT 9 0.0005
592 RENAL PAIN 5 0.0005
593 SLEEP APNOEA SYNDROME 9 0.0005
594 DYSGEUSIA 35 0.0005
595 SYNCOPE 47 0.0005
596 HYPERGLYCAEMIA 17 0.0005
597 HEREDITARY ANGIOEDEMA 5 0.0005
598 DEMENTIA 13 0.0005
599 BACK PAIN 108 0.0005
600 ARRHYTHMIA 22 0.0005
601 BLOOD MAGNESIUM DECREASED 4 0.0005
602 MUSCLE STRAIN 4 0.0005
603 PYELONEPHRITIS 4 0.0005
604 URINE OUTPUT DECREASED 4 0.0005
605 NAUSEA 361 0.0005
606 GROIN PAIN 4 0.0005
607 TUMOUR LYSIS SYNDROME 4 0.0005
608 SARS-COV-2 TEST POSITIVE 6 0.0005
609 HYPERSOMNIA 13 0.0005
610 IMMUNOSUPPRESSION 4 0.0005
611 FLUID RETENTION 23 0.0005
612 PURPURA 4 0.0005
613 ASTHENIA 169 0.0004
614 ABORTION SPONTANEOUS 18 0.0004
615 ACUTE MYELOID LEUKAEMIA 7 0.0004
616 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
617 HAEMOLYTIC ANAEMIA 4 0.0004
618 ADVERSE DRUG REACTION 40 0.0004
619 CYANOSIS 7 0.0004
620 FEEDING DISORDER 9 0.0004
621 HYPOTENSION 89 0.0004
622 DYSKINESIA 18 0.0004
623 WEIGHT DECREASED 123 0.0004
624 PELVIC PAIN 8 0.0004
625 SKIN LESION 12 0.0004
626 PRODUCT USE ISSUE 82 0.0004
627 SKIN DISCOLOURATION 20 0.0004
628 NEOPLASM 5 0.0004
629 MUSCLE TWITCHING 10 0.0004
630 ENCEPHALITIS 3 0.0004
631 RHINORRHOEA 28 0.0004
632 DIZZINESS 216 0.0004
633 RASH MACULAR 15 0.0004
634 HYPERKALAEMIA 15 0.0004
635 CHOLELITHIASIS 14 0.0004
636 FLANK PAIN 4 0.0004
637 PHOTOSENSITIVITY REACTION 7 0.0004
638 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
639 SINUS TACHYCARDIA 6 0.0004
640 SPINAL DISORDER 4 0.0004
641 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
642 DEAFNESS 11 0.0004
643 BRONCHOSPASM 6 0.0004
644 CATARACT 25 0.0004
645 CHOLECYSTITIS 5 0.0004
646 FLUID OVERLOAD 6 0.0004
647 BLOOD PRESSURE INCREASED 63 0.0004
648 CIRCULATORY COLLAPSE 7 0.0004
649 PARKINSONISM 4 0.0004
650 VITAMIN D DEFICIENCY 4 0.0004
651 CEREBRAL INFARCTION 10 0.0004
652 MELAENA 9 0.0004
653 BALANCE DISORDER 35 0.0004
654 RASH MACULO-PAPULAR 9 0.0004
655 PULMONARY MASS 6 0.0004
656 ILEUS 5 0.0004
657 TOOTH EXTRACTION 5 0.0004
658 RASH PAPULAR 9 0.0004
659 SECRETION DISCHARGE 5 0.0004
660 ANAEMIA 76 0.0004
661 COLD SWEAT 7 0.0004
662 CEREBROVASCULAR ACCIDENT 67 0.0004
663 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
664 DRUG ERUPTION 7 0.0004
665 TOOTH ABSCESS 4 0.0004
666 ACIDOSIS 3 0.0004
667 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
668 PRURITUS 150 0.0004
669 DYSPHAGIA 37 0.0004
670 OROPHARYNGEAL PAIN 36 0.0004
671 SKIN ULCER 10 0.0004
672 DELUSION 6 0.0004
673 EJECTION FRACTION DECREASED 6 0.0004
674 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
675 CONSTIPATION 84 0.0004
676 DRUG INTERACTION 61 0.0004
677 RESPIRATORY TRACT INFECTION 10 0.0004
678 UNINTENDED PREGNANCY 4 0.0004
679 NEUTROPENIA 52 0.0004
680 SOMNOLENCE 77 0.0004
681 WEIGHT FLUCTUATION 4 0.0004
682 TRANSFUSION 4 0.0004
683 IMMUNE SYSTEM DISORDER 5 0.0004
684 PRODUCT PRESCRIBING ERROR 9 0.0004
685 PRODUCTIVE COUGH 18 0.0004
686 SEPSIS 42 0.0004
687 JOINT INJURY 8 0.0004
688 DIARRHOEA 241 0.0004
689 SKIN CANCER 8 0.0004
690 HALLUCINATION 28 0.0004
691 UVEITIS 5 0.0004
692 DECUBITUS ULCER 3 0.0004
693 TACHYPNOEA 5 0.0004
694 POST PROCEDURAL COMPLICATION 7 0.0004
695 INFLUENZA LIKE ILLNESS 30 0.0004
696 ACUTE RESPIRATORY FAILURE 7 0.0004
697 RESPIRATORY ARREST 10 0.0004
698 ANAPHYLACTIC REACTION 20 0.0004
699 POLLAKIURIA 15 0.0004
700 AGGRESSION 18 0.0004
701 HYPERTENSIVE CRISIS 4 0.0004
702 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
703 BLOOD UREA INCREASED 6 0.0004
704 SKIN INFECTION 4 0.0004
705 ABDOMINAL PAIN LOWER 9 0.0004
706 RASH ERYTHEMATOUS 17 0.0004
707 HAEMATEMESIS 9 0.0004
708 MITRAL VALVE INCOMPETENCE 4 0.0004
709 PAIN IN JAW 10 0.0004
710 MYOCARDIAL ISCHAEMIA 4 0.0004
711 MICTURITION URGENCY 4 0.0003
712 MUSCULOSKELETAL DISCOMFORT 6 0.0003
713 METASTASES TO LUNG 4 0.0003
714 PLEURAL EFFUSION 21 0.0003
715 SEPTIC SHOCK 15 0.0003
716 INFLUENZA 38 0.0003
717 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
718 LABORATORY TEST ABNORMAL 10 0.0003
719 COVID-19 PNEUMONIA 4 0.0003
720 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
721 ATAXIA 4 0.0003
722 PSORIASIS 44 0.0003
723 GALLBLADDER DISORDER 6 0.0003
724 PULMONARY HYPERTENSION 7 0.0003
725 THIRST 6 0.0003
726 MACULAR DEGENERATION 4 0.0003
727 WRIST FRACTURE 4 0.0003
728 RENAL IMPAIRMENT 28 0.0003
729 HYPOAESTHESIA ORAL 5 0.0003
730 LEUKOCYTOSIS 6 0.0003
731 CORONARY ARTERY DISEASE 10 0.0003
732 NOCTURIA 4 0.0003
733 LOSS OF CONSCIOUSNESS 42 0.0003
734 DRUG DISPENSING ERROR 5 0.0003
735 PHARYNGEAL OEDEMA 5 0.0003
736 SMALL INTESTINAL OBSTRUCTION 4 0.0003
737 DEVICE RELATED INFECTION 5 0.0003
738 BRONCHITIS 24 0.0003
739 TENDON RUPTURE 4 0.0003
740 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
741 HEART RATE INCREASED 32 0.0003
742 TENDONITIS 5 0.0003
743 ERYTHEMA MULTIFORME 3 0.0003
744 HAIR COLOUR CHANGES 4 0.0003
745 DEFORMITY 3 0.0003
746 PNEUMONIA ASPIRATION 8 0.0003
747 COVID-19 56 0.0003
748 NEUTROPHIL COUNT DECREASED 13 0.0003
749 OFF LABEL USE 279 0.0003
750 PRODUCT USE COMPLAINT 5 0.0003
751 HEAD INJURY 10 0.0003
752 STEVENS-JOHNSON SYNDROME 7 0.0003
753 VISUAL IMPAIRMENT 39 0.0003
754 BURNING SENSATION 22 0.0003
755 MULTIPLE SCLEROSIS 15 0.0003
756 HYPOTHYROIDISM 10 0.0003
757 HYPOPHAGIA 8 0.0003
758 HYPOXIA 11 0.0003
759 HIP FRACTURE 10 0.0003
760 COUGH 87 0.0003
761 HEART RATE IRREGULAR 7 0.0003
762 HYPOGLYCAEMIA 15 0.0003
763 HIATUS HERNIA 4 0.0003
764 BLOOD POTASSIUM INCREASED 5 0.0003
765 PRODUCT AVAILABILITY ISSUE 7 0.0003
766 KIDNEY INFECTION 6 0.0003
767 ANKYLOSING SPONDYLITIS 4 0.0003
768 ABNORMAL BEHAVIOUR 12 0.0003
769 DEPRESSED MOOD 16 0.0003
770 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
771 VIRAL INFECTION 10 0.0003
772 BRAIN INJURY 3 0.0003
773 QUALITY OF LIFE DECREASED 4 0.0003
774 CANDIDA INFECTION 5 0.0003
775 DRY THROAT 3 0.0003
776 EPISTAXIS 22 0.0003
777 MYALGIA 50 0.0003
778 ANGIOEDEMA 13 0.0003
779 ACUTE HEPATIC FAILURE 4 0.0003
780 DYSPNOEA EXERTIONAL 11 0.0003
781 PLATELET COUNT DECREASED 31 0.0003
782 DYSPHONIA 17 0.0003
783 PARANOIA 5 0.0003
784 LOCALISED INFECTION 7 0.0003
785 ORAL DISCOMFORT 4 0.0003
786 RHABDOMYOLYSIS 12 0.0003
787 HUNGER 4 0.0003
788 HAEMOPTYSIS 8 0.0003
789 SPEECH DISORDER 15 0.0003
790 METASTASES TO LIVER 5 0.0003
791 HALLUCINATION, VISUAL 6 0.0003
792 BODY HEIGHT DECREASED 3 0.0003
793 LEUKOPENIA 14 0.0003
794 CARDIOGENIC SHOCK 4 0.0003
795 OVERDOSE 60 0.0003
796 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
797 FAECES DISCOLOURED 6 0.0003
798 DRUG ABUSE 23 0.0003
799 MENTAL DISORDER 12 0.0003
800 ACUTE KIDNEY INJURY 42 0.0003
801 BONE DISORDER 5 0.0003
802 PANIC ATTACK 10 0.0003
803 COMA 13 0.0003
804 PANCYTOPENIA 15 0.0003
805 ORAL PAIN 6 0.0003
806 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
807 HAEMORRHAGE INTRACRANIAL 4 0.0003
808 MUCOSAL INFLAMMATION 7 0.0003
809 FOOT FRACTURE 5 0.0003
810 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
811 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
812 HERPES ZOSTER 15 0.0003
813 RESPIRATORY FAILURE 19 0.0003
814 JAUNDICE 7 0.0003
815 ERYTHEMA 53 0.0003
816 NASAL CONGESTION 15 0.0003
817 MENORRHAGIA 5 0.0003
818 RESPIRATORY DISTRESS 7 0.0003
819 BACTERAEMIA 3 0.0003
820 DISORIENTATION 10 0.0003
821 PNEUMOTHORAX 4 0.0003
822 BLOOD PRESSURE ABNORMAL 5 0.0003
823 ULCER 4 0.0003
824 BLOOD PRESSURE FLUCTUATION 6 0.0002
825 BLOOD CREATININE INCREASED 16 0.0002
826 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
827 BLOOD PRESSURE DECREASED 16 0.0002
828 CYTOMEGALOVIRUS INFECTION 4 0.0002
829 DRY EYE 12 0.0002
830 RASH PRURITIC 13 0.0002
831 DERMATITIS ALLERGIC 3 0.0002
832 CARDIAC FAILURE 19 0.0002
833 PRODUCT QUALITY ISSUE 32 0.0002
834 SCAR 4 0.0002
835 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
836 EYE PAIN 13 0.0002
837 SWELLING FACE 15 0.0002
838 TREMOR 38 0.0002
839 EOSINOPHILIA 4 0.0002
840 GASTRITIS 6 0.0002
841 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
842 TRANSAMINASES INCREASED 5 0.0002
843 TOOTH DISORDER 5 0.0002
844 HEPATOTOXICITY 5 0.0002
845 GASTROENTERITIS VIRAL 4 0.0002
846 LIMB INJURY 6 0.0002
847 HAEMORRHAGE 23 0.0002
848 VISION BLURRED 30 0.0002
849 SUICIDAL IDEATION 20 0.0002
850 BLOOD GLUCOSE ABNORMAL 4 0.0002
851 PROCEDURAL PAIN 6 0.0002
852 APHONIA 3 0.0002
853 RENAL DISORDER 10 0.0002
854 THERAPEUTIC RESPONSE DECREASED 13 0.0002
855 BACTERIAL INFECTION 4 0.0002
856 BLINDNESS UNILATERAL 3 0.0002
857 TARDIVE DYSKINESIA 6 0.0002
858 BLOOD SODIUM DECREASED 4 0.0002
859 RENAL FAILURE ACUTE 9 0.0002
860 ACNE 16 0.0002
861 PROTEINURIA 4 0.0002
862 MUSCULOSKELETAL DISORDER 4 0.0002
863 CONVULSION 12 0.0002
864 GLAUCOMA 4 0.0002
865 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
866 CARDIAC ARREST 17 0.0002
867 PRESYNCOPE 5 0.0002
868 UNDERDOSE 15 0.0002
869 PSYCHOTIC DISORDER 6 0.0002
870 CARDIAC DISORDER 19 0.0002
871 OSTEONECROSIS OF JAW 5 0.0002
872 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
873 SKIN EXFOLIATION 17 0.0002
874 THROMBOSIS 16 0.0002
875 FLUSHING 20 0.0002
876 PRODUCT ADHESION ISSUE 7 0.0002
877 CEREBRAL HAEMORRHAGE 7 0.0002
878 FEELING ABNORMAL 46 0.0002
879 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
880 AGITATION 14 0.0002
881 SEIZURE 22 0.0002
882 BRADYCARDIA 10 0.0002
883 HOT FLUSH 14 0.0002
884 INTESTINAL OBSTRUCTION 7 0.0002
885 PAIN OF SKIN 5 0.0002
886 DISTURBANCE IN ATTENTION 10 0.0002
887 BLOOD BILIRUBIN INCREASED 5 0.0002
888 PRURITUS GENERALISED 4 0.0002
889 VAGINAL HAEMORRHAGE 8 0.0002
890 INCORRECT DOSE ADMINISTERED 42 0.0002
891 DIABETES MELLITUS 14 0.0002
892 TREATMENT NONCOMPLIANCE 10 0.0002
893 DRUG LEVEL INCREASED 3 0.0002
894 VISUAL ACUITY REDUCED 6 0.0002
895 COAGULOPATHY 3 0.0002
896 DRUG INEFFECTIVE 235 0.0002
897 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
898 DYSSTASIA 5 0.0002
899 HEART RATE DECREASED 6 0.0002
900 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
901 LYMPHADENOPATHY 6 0.0002
902 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
903 DISEASE RECURRENCE 8 0.0002
904 BLOOD POTASSIUM DECREASED 5 0.0002
905 END STAGE RENAL DISEASE 3 0.0002
906 DRUG ADMINISTRATION ERROR 5 0.0002
907 ADVERSE EVENT 15 0.0002
908 EMOTIONAL DISORDER 5 0.0002
909 ABASIA 4 0.0002
910 CONJUNCTIVITIS 3 0.0002
911 GYNAECOMASTIA 5 0.0002
912 HEPATIC FUNCTION ABNORMAL 6 0.0002
913 NEUROPATHY PERIPHERAL 15 0.0002
914 DRUG PRESCRIBING ERROR 3 0.0002
915 ERUCTATION 3 0.0002
916 UNRESPONSIVE TO STIMULI 4 0.0002
917 RASH GENERALISED 4 0.0002
918 OSTEONECROSIS 5 0.0002
919 DISEASE PROGRESSION 18 0.0002
920 LIP SWELLING 5 0.0001
921 FUNGAL INFECTION 5 0.0001
922 SKIN DISORDER 5 0.0001
923 IRRITABILITY 9 0.0001
924 FEAR 4 0.0001
925 BONE MARROW FAILURE 3 0.0001
926 GASTRIC DISORDER 5 0.0001
927 INTERSTITIAL LUNG DISEASE 7 0.0001
928 NEOPLASM PROGRESSION 5 0.0001
929 BLOOD GLUCOSE INCREASED 27 0.0001
930 FLATULENCE 8 0.0001
931 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
932 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
933 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
934 RENAL FAILURE 18 0.0001
935 THROAT IRRITATION 6 0.0001
936 LACRIMATION INCREASED 4 0.0001
937 PLASMA CELL MYELOMA 5 0.0001
938 OCULAR HYPERAEMIA 6 0.0001
939 MYOCARDIAL INFARCTION 22 0.0001
940 DEVICE BREAKAGE 5 0.0001
941 EYE DISORDER 4 0.0001
942 STAPHYLOCOCCAL INFECTION 4 0.0001
943 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
944 AGEUSIA 3 0.0001
945 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
946 ANGER 4 0.0001
947 CARDIOVASCULAR DISORDER 3 0.0001
948 BREAST CANCER 11 0.0001
949 ANAPHYLACTIC SHOCK 3 0.0001
950 DEVICE DISLOCATION 5 0.0001
951 CARDIAC FAILURE CONGESTIVE 9 0.0001
952 MYELOSUPPRESSION 4 0.0001
953 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
954 DRUG EFFECT INCOMPLETE 4 0.0001
955 ABNORMAL DREAMS 3 0.0001
956 SURGERY 6 0.0001
957 EMOTIONAL DISTRESS 12 0.0001
958 BLINDNESS 4 0.0001
959 BONE DENSITY DECREASED 3 0.0001
960 TOXICITY TO VARIOUS AGENTS 16 0.0001
961 DRUG EFFECT DECREASED 5 0.0001
962 UNEVALUABLE EVENT 7 0.0001
963 HOSPITALISATION 14 0.0001
964 DRY SKIN 12 0.0001
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
966 BLOOD GLUCOSE DECREASED 4 0.0001
967 CRYING 3 0.0001
968 DRUG WITHDRAWAL SYNDROME 7 0.0001
969 DRUG DOSE OMISSION 13 0.0001
970 PRODUCT DOSE OMISSION 5 0.0001
971 NERVOUSNESS 4 0.0001
972 INJECTION SITE BRUISING 6 0.0001
973 INJECTION SITE HAEMORRHAGE 6 0.0001
974 NEOPLASM MALIGNANT 5 0.0001
975 PRODUCT DOSE OMISSION ISSUE 22 0.0001
976 PROSTATE CANCER 6 0.0001
977 DEATH 63 0.0001
978 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
980 EYE IRRITATION 4 0.0001
981 DEVICE LEAKAGE 3 0.0001
982 ILLNESS 7 0.0001
983 SKIN BURNING SENSATION 4 0.0001
984 DEVICE ISSUE 5 0.0001
985 INJECTION SITE PAIN 17 0.0001
986 INJECTION SITE SWELLING 4 0.0001
987 NO ADVERSE EVENT 9 0.0000
988 COMPLETED SUICIDE 4 0.0000
989 DEVICE MALFUNCTION 3 0.0000
990 CHRONIC KIDNEY DISEASE 3 0.0000
991 DRUG DEPENDENCE 5 0.0000